Donald Olds - Net Worth and Insider Trading

Donald Olds Net Worth

The estimated net worth of Donald Olds is at least $2,874 dollars as of 2024-08-24. Donald Olds is the Director of Acasti Pharma Inc and owns about 1,173 shares of Acasti Pharma Inc (ACST) stock worth over $2,874. Details can be seen in Donald Olds's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Donald Olds has not made any transactions after 2023-08-31 and currently still holds the listed stock(s).

Transaction Summary of Donald Olds

To

Donald Olds Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Donald Olds owns 1 companies in total, including Acasti Pharma Inc (ACST) .

Click here to see the complete history of Donald Olds’s form 4 insider trades.

Insider Ownership Summary of Donald Olds

Ticker Comapny Transaction Date Type of Owner
ACST Acasti Pharma Inc 2023-08-31 director

Donald Olds Latest Holdings Summary

Donald Olds currently owns a total of 1 stock. Donald Olds owns 1,173 shares of Acasti Pharma Inc (ACST) as of August 31, 2023, with a value of $2,874.

Latest Holdings of Donald Olds

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ACST Acasti Pharma Inc 2023-08-31 1,173 2.45 2,874

Holding Weightings of Donald Olds


Donald Olds Form 4 Trading Tracker

According to the SEC Form 4 filings, Donald Olds has made a total of 1 transactions in Acasti Pharma Inc (ACST) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Acasti Pharma Inc is the acquisition of 381 shares on August 31, 2023, which cost Donald Olds around $781.

Insider Trading History of Donald Olds

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Donald Olds Trading Performance

GuruFocus tracks the stock performance after each of Donald Olds's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Donald Olds is 4.85%. GuruFocus also compares Donald Olds's trading performance to market benchmark return within the same time period. The performance of stocks bought by Donald Olds within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Donald Olds's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Donald Olds

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 35.12 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 39.99 LIMIT LIMIT LIMIT LIMIT LIMIT

Donald Olds Ownership Network

Ownership Network List of Donald Olds

No Data

Ownership Network Relation of Donald Olds

Insider Network Chart

Donald Olds Owned Company Details

What does Acasti Pharma Inc do?

Who are the key executives at Acasti Pharma Inc?

Donald Olds is the director of Acasti Pharma Inc. Other key executives at Acasti Pharma Inc include Chief Medical Officer R. Loch Macdonald , Chief Executive Officer Prashant Kohli , and VP Clinical Operations Carrie D'andrea .

Acasti Pharma Inc (ACST) Insider Trades Summary

Over the past 18 months, Donald Olds made 1 insider transaction in Acasti Pharma Inc (ACST) with a net purchase of 381. Other recent insider transactions involving Acasti Pharma Inc (ACST) include a net purchase of 676,371 shares made by Vimal Kavuru ,

In summary, during the past 3 months, insiders sold 0 shares of Acasti Pharma Inc (ACST) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Acasti Pharma Inc (ACST) were sold and 676,752 shares were bought by its insiders, resulting in a net purchase of 676,752 shares.

Acasti Pharma Inc (ACST)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Acasti Pharma Inc Insider Transactions

No Available Data

Donald Olds Mailing Address

Above is the net worth, insider trading, and ownership report for Donald Olds. You might contact Donald Olds via mailing address: 545 Promenade Du Centropolis, Suite 100, Laval A8 H7t 0a3.

Discussions on Donald Olds

No discussions yet.